• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于泛素相关基因的卵巢癌预后标志物鉴定提示 FBXO9 的潜在作用

Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.

机构信息

Department of Gynecology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Clinical and Translational Research Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai 200092, China.

出版信息

Biomolecules. 2023 Nov 30;13(12):1724. doi: 10.3390/biom13121724.

DOI:10.3390/biom13121724
PMID:38136595
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10742228/
Abstract

BACKGROUND

Ovarian cancer (OV) is associated with high mortality and poses challenges in diagnosis and prognosis prediction. Ubiquitin-related genes (UbRGs) are involved in the initiation and progression of cancers, but have still not been utilized for diagnosis and prognosis of OV.

METHODS

K48-linked ubiquitination in ovarian tissues from our OV and control cohort was assessed using immunohistochemistry. UbRGs, including ubiquitin and ubiquitin-like regulators, were screened based on the TCGA-OV and GTEx database. Univariate Cox regression analysis identified survival-associated UbRGs. A risk model was established using the LASSO regression and multivariate Cox regression analysis. The relationship between UbRGs and immune cell infiltration, tumor mutational burden, drug sensitivity, and immune checkpoint was determined using the CIBERSORT, ESTIMATE, and Maftools algorithms, based on the Genomics of Drug Sensitivity in Cancer and TCGA-OV databases. GEPIA2.0 was used to analyze the correlation between / and DNA damage repair-related genes. Finally, and were accessed in tissues or cells using immunohistochemistry, qPCR, and Western blot.

RESULTS

We confirmed the crucial role for ubiquitination in OV as a significant decrease of K48-linked ubiquitination was observed in primary OV lesions. We identified a prognostic signature utilizing two specific UbRGs, and . The risk score obtained from this signature accurately predicted the overall survival of TCGA-OV training dataset and GSE32062 validation dataset. Furthermore, this risk score also showed association with immunocyte infiltration and drug sensitivity, revealing potential mechanisms for ubiquitination mediated OV risk. In addition, , but not , was found to be downregulated in OV and positively correlated with DNA damage repair pathways, suggesting as a potential cancer suppressor, likely via facilitating DNA damage repair.

CONCLUSIONS

We identified and validated a signature of UbRGs that accurately predicts the prognosis, offers valuable guidance for optimizing chemotherapy and targeted therapies, and suggests a potential role for in OV.

摘要

背景

卵巢癌(OV)死亡率高,诊断和预后预测存在挑战。泛素相关基因(UbRGs)参与癌症的发生和进展,但尚未用于 OV 的诊断和预后。

方法

采用免疫组织化学法检测卵巢组织中 K48 连接泛素化。基于 TCGA-OV 和 GTEx 数据库筛选 UbRGs,包括泛素和泛素样调节剂。单因素 Cox 回归分析鉴定与生存相关的 UbRGs。采用 LASSO 回归和多因素 Cox 回归分析建立风险模型。基于癌症基因组药物敏感性和 TCGA-OV 数据库,采用 CIBERSORT、ESTIMATE 和 Maftools 算法确定 UbRGs 与免疫细胞浸润、肿瘤突变负荷、药物敏感性和免疫检查点的关系。利用 GEPIA2.0 分析与 DNA 损伤修复相关基因的相关性。最后,采用免疫组织化学、qPCR 和 Western blot 检测组织或细胞中的和。

结果

我们证实泛素化在 OV 中起关键作用,因为在原发性 OV 病变中观察到 K48 连接泛素化显著减少。我们利用两个特定的 UbRGs 和鉴定出一个预后标志。该标志物获得的风险评分可准确预测 TCGA-OV 训练数据集和 GSE32062 验证数据集的总生存期。此外,该风险评分还与免疫细胞浸润和药物敏感性相关,揭示了泛素介导的 OV 风险的潜在机制。此外,在 OV 中发现下调,与 DNA 损伤修复途径呈正相关,表明可能作为一种潜在的癌症抑制因子,通过促进 DNA 损伤修复发挥作用。

结论

我们鉴定并验证了一个 UbRGs 标志,可准确预测预后,为优化化疗和靶向治疗提供有价值的指导,并提示在 OV 中可能发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/fabb8d745782/biomolecules-13-01724-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/ec43e4fe9b82/biomolecules-13-01724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/21da96780a14/biomolecules-13-01724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/ac164e4d0ce8/biomolecules-13-01724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/f0942919ca77/biomolecules-13-01724-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/af757b5e2b3d/biomolecules-13-01724-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/784fbe6b6c8e/biomolecules-13-01724-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/d6e3a1fc9f66/biomolecules-13-01724-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/905cbcf1820c/biomolecules-13-01724-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/fabb8d745782/biomolecules-13-01724-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/ec43e4fe9b82/biomolecules-13-01724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/21da96780a14/biomolecules-13-01724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/ac164e4d0ce8/biomolecules-13-01724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/f0942919ca77/biomolecules-13-01724-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/af757b5e2b3d/biomolecules-13-01724-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/784fbe6b6c8e/biomolecules-13-01724-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/d6e3a1fc9f66/biomolecules-13-01724-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/905cbcf1820c/biomolecules-13-01724-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ec6/10742228/fabb8d745782/biomolecules-13-01724-g009.jpg

相似文献

1
Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.基于泛素相关基因的卵巢癌预后标志物鉴定提示 FBXO9 的潜在作用
Biomolecules. 2023 Nov 30;13(12):1724. doi: 10.3390/biom13121724.
2
Prognostic Signature, Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma.肺腺癌中一种新型泛素化相关基因特征的预后特征、免疫特性及治疗反应
J Oncol. 2022 Aug 16;2022:2524649. doi: 10.1155/2022/2524649. eCollection 2022.
3
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer.一种新型的与染色体外环状 DNA 相关的基因特征,可用于预测卵巢癌患者的总生存期。
BMC Med Genomics. 2023 Jun 19;16(1):140. doi: 10.1186/s12920-023-01576-x.
4
Assessing of programmed cell death gene signature for predicting ovarian cancer prognosis and treatment response.评估细胞程序性死亡基因特征预测卵巢癌预后和治疗反应。
Front Endocrinol (Lausanne). 2023 Jun 5;14:1182776. doi: 10.3389/fendo.2023.1182776. eCollection 2023.
5
Establishment of an ovarian cancer omentum metastasis-related prognostic model by integrated analysis of scRNA-seq and bulk RNA-seq.基于单细胞 RNA 测序和 bulk RNA 测序综合分析建立卵巢癌腹膜转移相关预后模型。
J Ovarian Res. 2022 Nov 23;15(1):123. doi: 10.1186/s13048-022-01059-0.
6
A novel autophagy-related gene signature associated with prognosis and immune microenvironment in ovarian cancer.一种与卵巢癌预后和免疫微环境相关的新型自噬相关基因特征。
J Ovarian Res. 2023 Apr 29;16(1):86. doi: 10.1186/s13048-023-01167-5.
7
A Novel pyroptosis-related signature for predicting prognosis and evaluating tumor immune microenvironment in ovarian cancer.一种新的与细胞焦亡相关的特征可用于预测卵巢癌的预后和评估肿瘤免疫微环境。
J Ovarian Res. 2023 Sep 20;16(1):196. doi: 10.1186/s13048-023-01275-2.
8
Prognostic and Immune Landscape Analysis of Ubiquitination-related Genes in Hepatocellular Carcinoma: Based on Bulk and Single-cell RNA Sequencing Data.肝细胞癌中泛素化相关基因的预后及免疫图谱分析:基于批量和单细胞RNA测序数据
J Cancer. 2024 Mar 11;15(9):2580-2600. doi: 10.7150/jca.93425. eCollection 2024.
9
Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients.鉴定与糖酵解相关的基因特征,用于预测卵巢癌患者的生存情况。
Cancer Med. 2021 Nov;10(22):8222-8237. doi: 10.1002/cam4.4317. Epub 2021 Oct 5.
10
A Novel Platinum Resistance-Related Immune Gene Signature for Overall Survival Prediction in Patients with Ovarian Cancer.一种新型铂类耐药相关免疫基因标志物,用于预测卵巢癌患者的总生存期。
Biochem Genet. 2024 Feb;62(1):112-124. doi: 10.1007/s10528-023-10379-9. Epub 2023 Jun 4.

引用本文的文献

1
Comprehensive analysis Neddylation-related genes identified UBB as a prognostic biomarker for clear cell renal cell carcinoma.对与Neddylation相关基因的综合分析确定了泛素B为透明细胞肾细胞癌的一种预后生物标志物。
Discov Oncol. 2025 May 22;16(1):859. doi: 10.1007/s12672-025-02547-7.
2
Development and evaluation of an ovarian cancer prognostic model based on adaptive immune-related genes.基于适应性免疫相关基因的卵巢癌预后模型的构建与评估
Medicine (Baltimore). 2025 Apr 4;104(14):e42030. doi: 10.1097/MD.0000000000042030.
3
A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer.

本文引用的文献

1
Endoplasmic Reticulum Stress-Related Ten-Biomarker Risk Classifier for Survival Evaluation in Epithelial Ovarian Cancer and : A Potential Therapeutic Target of Ovarian Cancer.内质网应激相关的十标志物风险分类器用于上皮性卵巢癌的生存评估:卵巢癌的潜在治疗靶点。
Int J Mol Sci. 2023 Sep 12;24(18):14010. doi: 10.3390/ijms241814010.
2
Cellular Functions of Deubiquitinating Enzymes in Ovarian Adenocarcinoma.去泛素化酶在卵巢腺癌中的细胞功能。
Genes (Basel). 2023 Apr 9;14(4):886. doi: 10.3390/genes14040886.
3
Construction of Ovarian Cancer Prognostic Model Based on the Investigation of Ferroptosis-Related lncRNA.
一种基于新型泛素相关基因的特征在喉癌的预后预测、免疫格局塑造和治疗选择方面显示出价值。
Front Pharmacol. 2025 Mar 20;16:1513948. doi: 10.3389/fphar.2025.1513948. eCollection 2025.
4
Comprehensive analysis identifies ubiquitin ligase FBXO42 as a tumor-promoting factor in neuroblastoma.综合分析鉴定泛素连接酶 FBXO42 为神经母细胞瘤中的肿瘤促进因子。
Sci Rep. 2024 Aug 12;14(1):18697. doi: 10.1038/s41598-024-69760-2.
基于铁死亡相关 lncRNA 研究的卵巢癌预后模型的构建。
Biomolecules. 2023 Feb 6;13(2):306. doi: 10.3390/biom13020306.
4
Cancer statistics, 2023.癌症统计数据,2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
5
A novel defined risk signature of endoplasmic reticulum stress-related genes for predicting the prognosis and immune infiltration status of ovarian cancer.一种新型的内质网应激相关基因风险特征可用于预测卵巢癌的预后和免疫浸润状态。
J Zhejiang Univ Sci B. 2023 Jan 15;24(1):64-77. doi: 10.1631/jzus.B2200272.
6
Targeting DNA damage response pathways in cancer.靶向癌症中的DNA损伤反应通路。
Nat Rev Cancer. 2023 Feb;23(2):78-94. doi: 10.1038/s41568-022-00535-5. Epub 2022 Dec 5.
7
Upregulated Ubiquitin D is a Favorable Prognostic Indicator for Rectal Cancer Patients Undergoing Preoperative Concurrent Chemoradiotherapy.上调的泛素D是接受术前同步放化疗的直肠癌患者的良好预后指标。
Onco Targets Ther. 2022 Oct 11;15:1171-1181. doi: 10.2147/OTT.S378666. eCollection 2022.
8
The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer.m6A相关长链非编码RNA特征预测卵巢癌预后并指示肿瘤免疫浸润
Cancers (Basel). 2022 Aug 22;14(16):4056. doi: 10.3390/cancers14164056.
9
Identification of Ubiquitin-Related Gene-Pair Signatures for Predicting Tumor Microenvironment Infiltration and Drug Sensitivity of Lung Adenocarcinoma.用于预测肺腺癌肿瘤微环境浸润和药物敏感性的泛素相关基因对特征的鉴定
Cancers (Basel). 2022 Jul 18;14(14):3478. doi: 10.3390/cancers14143478.
10
FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma.FBXO9通过降解FBXW7介导ZNF143的促癌作用并促进肝细胞癌的耐药性。
Front Oncol. 2022 Jun 30;12:930220. doi: 10.3389/fonc.2022.930220. eCollection 2022.